Showing results (501-510 of 911) with videos related to
Sort By:
Pageof 92
Therapeutics and Clinical Risk Management|March 28, 2014
Medication transitions and polypharmacy in older adults following acute careJohn-Michael Gamble, Jill J Hall, Thomas J Marrie, et al.Advanced Materials (Deerfield Beach, Fla.)|October 12, 2012
Plasmid-templated shape control of condensed DNA-block copolymer nanoparticlesXuan Jiang, Wei Qu, Deng Pan, et al.The European Journal of Neuroscience|October 1, 2018
Recurring circadian disruption alters circadian clock sensitivity to resettingTanya L Leise, Ariella Goldberg, John Michael, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 3, 2023
Comparison of aortic valve repair techniques with single- and double-ring annuloplastiesLeila Louise Benhassen, Jacob Hesselby Hedensted, Mona Sharghbin, et al.Journal of Applied Behavior Analysis|January 19, 2024
Further evidence of renewal in automatically maintained behaviorJohn Michael Falligant, Michael P Kranak, Drew E Piersma, et al.Stem Cells Translational Medicine|January 12, 2018
Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft DysfunctionCesar Ariel Keller, Thomas Arthur Gonwa, David Orel Hodge, et al.Proceedings of the National Academy of Sciences of the United States of America|April 16, 2025
Quantifying the impact of biobanks and cohort studiesRodrigo Dorantes-Gilardi, Kerry L Ivey, Lauren Costa, et al.Frontiers in Neurology|August 28, 2020
Neuroimmunogastroenterology: At the Interface of Neuroimmunology and GastroenterologyJohn Michael S Sanchez, J Scott McNally, Melissa M Cortez, et al.Pharmacoepidemiology and Drug Safety|March 12, 2013
Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure dataJohn-Michael Gamble, Jeffrey A Johnson, Sumit R Majumdar, et al.Clinical Therapeutics|January 19, 2015
Limited impact of drug exposure misclassification from non-benefit thiazolidinedione drug use on mortality and hospitalizations from Saskatchewan, Canada: a cohort studyJohn-Michael Gamble, Jeffrey A Johnson, Finlay A McAlister, et al.Pageof 92